Patent · US Active

Pharmaceutical composition

US10792256B2 · kind B2 · utility

9Cited by

6References

46Claims

0Family size

Assignee

MEXICHEM FLUOR S.A. DE C.V. · MX

Inventors

Stuart Corr · Appleton, GB
Timothy James Noakes · Winchester, GB

Key dates

Filing date	Sep 18, 2017
Grant date	Oct 6, 2020
Priority date	—
Expiry date	Sep 18, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition is described. The composition comprises: (i) a drug component comprising at least one salmeterol compound selected from salmeterol and the pharmaceutically acceptable derivatives thereof; and (ii) a propellant component comprising 1,1-difluoroethane (HFA-152a).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.